Abstract
Public bioethics advisory bodies have been a staple of US public policy for addressing public biotechnology- related controversies, in spite of the limited impact these bodies have had on policy-making. These advisory bodies serve an important tacit function as boundary organizations that stabilize the border between science and politics, preserving the autonomy of science from incursion by other societal stakeholders. In this paper the boundary work of the US National Bioethics Advisory Commission is examined at the border of science and ethics, in its deliberations on embryonic stem cell research. The coupling of scientific and ethical uncertainty, and that of research productivity and integrity assurance in the Commission's deliberations is described. It is argued that the Commission's boundary work reinforced the authority of science and marginalized conflicting civic-sector concerns. Copyright , Beech Tree Publishing.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
